How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

MIDA sees broader investment pipeline beyond data centres in 2026
Malaysia likely see net foreign equity inflow in 2026 amid rising investor confidence
Sarawak to introduce carbon levy on oil, gas and energy sectors
Astro to stop new Astro Fibre sign-ups from Feb 2026
5E Resources secures Bursa Malaysia nod for ACE Market listing
Ringgit ends higher as Trump-fed clash weakens the greenback
AirAsia X fully secures RM1bil private placement at RM1.65 per share
iCents wins RM9.12mil industrial facility contract
Rimbunan Sawit disposes of land for RM28mil
Agibot opens Malaysia’s first AI and robotics experience centre

Others Also Read